SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405:
SEC Accession No. 0001493152-19-004731
Filing Date
2019-04-02
Accepted
2019-04-02 17:00:32
Documents
1
Period of Report
2018-12-31
Effectiveness Date
2019-04-02

Document Format Files

Seq Description Document Type Size
1 nt10-k.htm NT 10-K 39183
  Complete submission text file 0001493152-19-004731.txt   40532
Mailing Address 4721 EMPEROR BOULEVARD SUITE 350 DURHAM NC 27703
Business Address 4721 EMPEROR BOULEVARD SUITE 350 DURHAM NC 27703 919-578-5901
Adhera Therapeutics, Inc. (Filer) CIK: 0000737207 (see all company filings)

IRS No.: 112658569 | State of Incorp.: DE | Fiscal Year End: 1231
Type: NT 10-K | Act: 34 | File No.: 000-13789 | Film No.: 19725950
SIC: 2834 Pharmaceutical Preparations